World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
32875
World Ranking
17830
National Ranking
670

Johannes L. Peterse publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Johannes L. Peterse sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 209 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Johannes L. Peterse D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Johannes L. Peterse sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Johannes L. Peterse is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their work is situated within a clinical and research environment that focuses on medical sciences, particularly in oncology and related fields, given the hospital's specialization.

While specific papers, co-authors, publication venues, and detailed research topics are not listed, the professional association with a leading cancer hospital suggests involvement in studies related to cancer diagnosis, treatment, or pathology. The absence of listed recent publications or book titles, however, limits a detailed overview of their research output.

The Antoni van Leeuwenhoek Hospital is recognized for integrating clinical care with biomedical research, indicating that Peterse's role there may span both patient care and translational research efforts. This dual focus is common in institutions that aim to bridge laboratory discoveries with practical therapeutic approaches.

Information on awards or honors has not been recorded, and there are no noted subfields or main research topics linked to this name from the provided data.

Due to the limited availability of comprehensive bibliometric data or thematic research areas, further details on Peterse's specific contributions, publication history, or collaborations remain unavailable from the current source.

Best Publications

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Breast cancer metastasis: markers and models

    Britta Weigelt;Johannes L Peterse;Laura J van 't Veer

  • Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

    van de Vijver Mj;Peterse Jl;Mooi Wj;Wisman P

  • Ductal carcinoma in situ: a proposal for a new classification.

    R Holland;J L Peterse;R R Millis;V Eusebi

  • Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

    Adri C. Voogd;Maja Nielsen;Johannes L. Peterse;Mogens Blichert-Toft

  • Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

    Jean-Pierre Julien;Nina Bijker;Ian S Fentiman;Johannes L Peterse

  • Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

    Patrick W.B. Derksen;Xiaoling Liu;Francis Saridin;Hanneke van der Gulden

  • Risk Factors for Recurrence and Metastasis After Breast-Conserving Therapy for Ductal Carcinoma-In-Situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853

    N Bijker;J L Peterse;L Duchateau;J P Julien

  • Refinement of breast cancer classification by molecular characterization of histological special types.

    B Weigelt;H M Horlings;B Kreike;M M Hayes

  • Gene expression profiles of primary breast tumors maintained in distant metastases.

    Britta Weigelt;Annuska M. Glas;Lodewyk F. A. Wessels;Anke T. Witteveen

  • Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

    Xiaoling Liu;Henne Holstege;Hanneke van der Gulden;Marcelle Treur-Mulder

  • Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project☆

    P.J. van Diest;J.P.A. Baak;P. Matze-Cok;E.C.M. Wisse-Brekelmans

  • Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.

    M van de Vijver;R van de Bersselaar;P Devilee;C Cornelisse

  • Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer

    E.E Deurloo;P.J Tanis;K.G.A Gilhuijs;S.H Muller

  • E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

    C. B. J. Vos;A. M. Cleton-Jansen;G. Berx;W. J. F. De Leeuw

  • Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

    I F Faneyte;J G Schrama;J L Peterse;P L Remijnse

  • Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

    W. J. F. De Leeuw;G. Berx;C. B. J. Vos;J. L. Peterse

  • Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

    Sjoerd Rodenhuis;Dick J. Richel;Elsken Van Der Wall;Jan H. Schornagel

  • Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

    Jolien M. Bueno-de-Mesquita;Wim H. van Harten;Valesca P. Retel;Laura J. van't Veer

  • Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

    Heather A. Jones;Ninja Antonini;Augustinus A.M. Hart;Johannes L. Peterse

Frequent Co-Authors

Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Omgo E. Nieweg
Omgo E. Nieweg Royal Prince Alfred Hospital
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam
Cees J. Cornelisse
Cees J. Cornelisse Leiden University Medical Center
Anna Sapino
Anna Sapino University of Turin
C.W. Elston
C.W. Elston University of Nottingham
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary pathways to studying Medicine in the USA can open new doors for your healthcare career. Many students opt for advanced nursing degrees or specialized programs to accelerate their professional journey and broaden their expertise.

For those aiming for leadership positions in the medical field, shortest dnp programs online can offer a fast track to a Doctor of Nursing Practice, combining academic excellence with flexible online schedules. Meanwhile, affordability matters—cheapest dnp programs can help minimize student debt and make advanced qualifications more accessible.

If you’re keen to get started in healthcare quickly, fast track medical lpn programs can prepare you for practical nursing roles in a matter of months. For those interested in mental health, accelerated msn psychiatric np programs lead to advanced practice as psychiatric nurse practitioners, providing rapid specialization in a high-demand area.

These online degree options offer flexibility, cost-effectiveness, and faster routes into crucial healthcare roles, making them excellent alternatives or stepping stones for your medical career journey.

Best Scientists Citing Johannes L. Peterse

Recently Published Articles